Companies: 10,795·Total market cap: $144.5T
Alumis Inc. Common Stock

Alumis Inc. Common Stock

ALMSNASDAQHealthcare● Active
$19.30
+$0.24(+1.25%)
Market Cap$2.4B
P/E Ratio
52W High$30.6
52W Low$2.76

Alumis Inc. Common Stock (ALMS) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ALMS · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was −$370.2M for FY2025 (fiscal year ending 2025-12-31), down 44.1% year-over-year

FY2025 Free Cash Flow−$370.2M▼ -44.1% YoY
Trailing 12M (TTM)−$377.0Mtrailing 4 quarters sum
FCF Margin< −999%−$370.2M ÷ revenue
3-Year CAGRN/AN/A — contains negative FCF
5-Year CAGRN/AN/A — contains negative FCF
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
alms free cash flow history · alms free cash flow chart · alms free cash flow growth rate · alms free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest−$370.2M▼ 44.1%
FY2024−$256.8M▼ 91.0%
FY2023−$134.5M▼ 22.1%
FY2022−$110.1M
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
alms free cash flow 2025 · alms free cash flow 2024 · alms free cash flow 2023 · alms operating cash flow

FCF valuation metrics

Alumis Inc. Common Stock (ALMS) reported negative free cash flow of −$0.37B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)
N/A
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
N/A
TTM FCF ÷ Shares Outstanding
Price / FCF
N/A
Share Price ÷ FCF per Share
EV / FCF (TTM)
N/A
Enterprise Value basis
!

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31
alms price to free cash flow · alms free cash flow yield · alms free cash flow per share · alms price to cash flow ratio

Cash flow statement summary

For FY2025, Alumis Inc. Common Stock generated −$369.5M in operating cash flow and spent 1M in capital expenditures, yielding −$370.2M in free cash flow.

Operating Activities
−$369.5M
Cash from core business operations
2025-12-31
Investing Activities
+$287.9M
CapEx, acquisitions & investments
2025-12-31
Financing Activities
+$2.1M
Buybacks, dividends & debt
2025-12-31
FCF FormulaOperating CF (−$369.5M) − |CapEx| (1M) = FCF (−$370.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
alms cash flow statement · alms cash flow statement 2025 · alms operating cash flow · alms cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Alumis Inc. Common Stock
Alumis Inc. Common StockYOU
ALMS
−$370.2M-44.1%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Alumis Inc. Common Stock (ALMS) reported free cash flow of −$370.2M for FY2025 (fiscal year ending 2025-12-31), down 44.1% year-over-year.

Alumis Inc. Common Stock has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 4 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

ALMS free cash flow · 8 questions

Alumis Inc. Common Stock free cash flow was −$370.2M for FY2025, down 44.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$377.0M.

ALMS free cash flowALMS FCFALMS FCF 2025ALMS free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · Alumis Inc. Common Stock · Alumis Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026